With renewed leadership, FDA clearance for QP-Prostate CAD and a $50M Series A, Quibim enters a new era of growth and strategic expansion that will certainly scale and shape the future of precision healthcare. Introducing our new Board of Directors: ▪️ Tom Tynes, Founder of T2 MedTech, LLC (Independent Director) ▪️ Pierre Socha, Partner at Amadeus Capital Partners ▪️ Romain Lavault, General Partner at Partech ▪️ Guillem Masferrer, Partner at Asabys Partners ▪️ Jose Mesa, Partner at COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U. and Buenavista Equity Partners (formerly GED Capital)’s representative on the Board ▪️ Dr. Ángel Alberich-Bayarri, CEO & Co-Founder of Quibim One of the new members of the Board of Directors is Tom Tynes, who joins as an independent director. Tom brings a wealth of experience, having led the launch, profitable growth, and success of several medical device companies over the past 30 years. https://bit.ly/4i6Qczc
💊 AI is transforming how we develop new treatments, accelerating the path from discovery to #patientcare. By leveraging machine learning, data mining, and predictive modeling, AI is optimizing every stage of drug development—making the process faster, smarter, and more precise. #MachineLearning #MedicalInnovation #AIinHealth
CADt, CADe, CADx – What’s the Difference? AI-based computer-aided triage (CADt), detection (CADe) and diagnosis (CADx) are becoming increasingly important in medical imaging: ⚡ 𝐂𝐀𝐃𝐭 – Identifies potentially urgent cases to prioritize their review, without making a diagnosis. 🩺 𝐂𝐀𝐃𝐞 – Flags suspicious regions on medical images to assist as a second reader. 🔬 𝐂𝐀𝐃𝐱 – Analyzes and characterizes lesions to support diagnostic decisions. So... is CADe/x a game-changer in radiology? We break it all down in our latest blog 👉 https://bit.ly/4hZIuaa #AIinHealthcare #Radiology #MedicalImaging #AIPoweredCAD #PrecisionMedicine
March was a month of major milestones at Quibim! ✅ The FDA cleared QP-Prostate® CAD — great news for U.S. specialists who can now access our AI-powered tool designed to reveal hidden cases of aggressive #ProstateCancer. 💡 We also shared expert insights from Antonio José Conde Moreno MD PhD MSc and Prof. Shonit Punwani, and published new research on neuroblastoma in 𝘍𝘳𝘰𝘯𝘵𝘪𝘦𝘳𝘴 𝘪𝘯 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺. 🚀 Let’s not forget our latest innovations showcased at #ECR25. Catch up on all the highlights in our newsletter 👇 #AIinHealthcare #CancerScreening #Innovation
💡 Great insights and hands-on learning at #ALIP2024! Claire Palacin, David Bazaga and Kenza B. represented the hashtag#QuibimTeam at this year’s Ateliers Lillois d’Imagerie de la Prostate in Lille. From engaging in practical sessions to exchanging ideas with top prostate imaging experts, the experience pushed the boundaries of what’s possible in AI-driven prostate cancer care. A big thank you to all participants and especially Prof. Philippe PUECH for making it such a forward-thinking event. #AI #MedicalImaging #ProstateCancer #Innovation
🏆 We’re proud to announce that Quibim has achieved 3rd Position in the 50-100 employees category in the Best Companies to Work For in Spain – #BestWorkplaces25! This recognition, unveiled at the awards gala in Madrid by Great Place To Work Spain®, is a testament to one of our key values: people-first culture and well-being at work. For this year’s edition, 452 companies were analyzed and the opinions of 425.342 employees were collected. To our amazing team—thank you. Let’s keep growing together! #GreatPlaceToWork #CompanyCulture #TeamQuibim #LifeAtQuibim #WorkplaceWellbeing
🚨 Tomorrow we will be at the 14th edition of 𝘈𝘵𝘦𝘭𝘪𝘦𝘳𝘴 𝘓𝘪𝘭𝘭𝘰𝘪𝘴 𝘐𝘮𝘢𝘨𝘦𝘳𝘪𝘦 𝘗𝘳𝘰𝘴𝘵𝘢𝘵𝘦 (ALIP) in Lille! We’re thrilled to be one of the main sponsors of this prestigious event, organized by Prof. Philippe PUECH and dedicated to advancing #ProstateCancerImaging. This hands-on workshop brings together top French-speaking experts to explore: 🔹 PI-RADS scoring 🔹 MRI-guided biopsies 🔹 How AI is transforming clinical decision-making Thank you, Prof. Puech, for the invitation – we look forward to engaging discussions and knowledge sharing! #AIinHealthcare #MedicalImaging #ProstateCancerResearch #Radiology #AIinRadiology
Demand for computing, connectivity and digital services is skyrocketing, but challenges such as limited capacity, energy supply and sustainability threaten this momentum. To drive transformation, Barcelona & Partners, investment attraction agency of Barcelona Global organized a high-level roundtable where our CEO and Co-founder, Ángel Alberich-Bayarri, joined other senior executives to define a roadmap for the city's digital future. In his words, a key solution lies in the shift towards an AI-driven infrastructure to support deep tech companies and big data processing, ensuring that Barcelona remains a key hub for AI-specialized compute centers. 🤝 Collaboration is key to making this vision a reality-stay tuned for next steps. #Makeithappen #Barcelona #Data #Innovation #AIInnovation
Ahead of #ECR2025, we had the privilege of speaking with Professor Shonit Punwani—an expert in MRI technology and #prostatecancer imaging. As a Professor of Magnetic Resonance and Oncological Imaging at University College London (UCL), Consultant Radiologist at University College London Hospitals NHS Foundation Trust (UCLH), and Medical Advisor to Quibim, he shared revealing insights on the groundbreaking advances shaping the future of #patientcare. 🗞️ Curious to learn more about his thoughts? Read the full conversation here: https://bit.ly/4bdB1lV #CancerCare #AIInHealthcare #MedicalImaging #MRI
Mark was just 59 when he lost his battle with prostate cancer. But his legacy lives on. Before he passed, Mark urged his friends to get tested. Two of them were diagnosed early and credited Mark with saving their lives. His widow, Karen, now supports our campaign to make prostate cancer screening accessible to all. She says, “If screening had been available, Mark might still be here today.” 💙 Let’s honour Mark by pushing for change. Join the movement for screening reform. Together, we will save lives. Sign up today: https://lnkd.in/edpXwGm8
